What Is Xerostomia?
Xerostomia is the subjective sensation of dry mouth. Although frequently used as a synonym for "insufficient saliva production," xerostomia refers specifically to the patient's complaint — the perception that the mouth is dry or uncomfortable.
It is essential to distinguish xerostomia from salivary gland hypofunction (hyposalivation), which is the objectively measurable reduction in salivary flow. Not all patients with xerostomia have a real reduction in saliva production, and not all hyposalivation causes perceptible symptoms.
Saliva performs essential functions: lubrication of oral tissues, protection against caries through enamel remineralization, antimicrobial action (lysozyme, lactoferrin, immunoglobulin A), facilitation of chewing, swallowing, and speech, and participation in the initial digestion of starches by salivary amylase.
Subjective Complaint
Xerostomia is the sensation of dry mouth, which may exist with or without a real reduction in salivary flow.
High Prevalence
Affects about 20% of the general population, reaching 30-40% in older adults and more than 70% in patients irradiated for head and neck cancer.
Broad Impact
Compromises eating, speech, dental health, and quality of life, and can lead to recurrent oral infections.
Pathophysiology
Normal salivary production is 0.5 to 1.5 liters per day, generated by three pairs of major salivary glands — parotid, submandibular, and sublingual — in addition to hundreds of minor salivary glands distributed throughout the oral mucosa. Salivary secretion is controlled by the autonomic nervous system, with parasympathetic predominance.
Parasympathetic stimulation (via the facial nerve — cranial nerve VII — and the glossopharyngeal nerve — cranial nerve IX) releases acetylcholine, which activates M3 muscarinic receptors on acinar cells, promoting abundant aqueous secretion. Sympathetic stimulation (via norepinephrine on beta-adrenergic receptors) produces more viscous, protein-rich saliva.
Main Causes of Xerostomia
Medications are the most common cause. More than 500 drugs list xerostomia as an adverse effect. The main ones are anticholinergics, tricyclic antidepressants, selective serotonin reuptake inhibitors (SSRIs), antihistamines, antihypertensives (diuretics, beta-blockers), opioids, and benzodiazepines. The predominant mechanism is blockade of M3 muscarinic receptors.
Radiation therapy to the head and neck region is the most devastating cause. Doses above 30 Gy to the salivary glands cause irreversible destruction of the acinar parenchyma, with fibrosis and permanent loss of function. The parotid gland is particularly radiosensitive.
Sjögren syndrome is the most important autoimmune cause. Lymphocytic infiltration progressively destroys the salivary and lacrimal glands, resulting in xerostomia and xerophthalmia (dry eye). Diabetes mellitus, dehydration, and aging (a 25-30% reduction in secretory capacity after age 65) are additional relevant causes.
Symptoms
The symptoms of xerostomia affect multiple oral functions and can vary from mild discomfort to severe impairment of quality of life. The intensity depends on the degree of salivary reduction and the underlying cause.
Symptoms of Xerostomia
- 01
Persistent sensation of dry mouth
Sensation of "cotton mouth," especially upon waking or when speaking for prolonged periods.
- 02
Difficulty chewing and swallowing dry foods
Foods such as bread, crackers, and dry meats stick to the mucosa and are difficult to swallow without liquids.
- 03
Taste alterations (dysgeusia)
Reduction or distortion of food flavors, particularly salty and bitter tastes.
- 04
Burning or scalding sensation in the mouth
Burning sensation on the tongue, palate, and buccal mucosa, which may mimic burning mouth syndrome.
- 05
Halitosis (bad breath)
Salivary reduction allows anaerobic bacterial proliferation, responsible for the production of volatile sulfur compounds.
- 06
Fissures on the lips and corners of the mouth
Angular cheilitis (fissures at the labial commissures) is frequent and can facilitate Candida infection.
- 07
Increase in dental caries
Without the protection of saliva, caries appear in atypical locations: smooth surfaces, gingival margins, and incisal edges.
- 08
Difficulty speaking
The tongue sticks to the palate and speech becomes pasty, especially during prolonged periods.
Diagnosis
The diagnosis of xerostomia is clinical, based on the patient's complaint and physical examination findings. To quantify hyposalivation, sialometry is used — measurement of salivary flow at rest and stimulated.
Normal resting salivary flow is 0.3 to 0.4 mL/min. Values below 0.1 mL/min characterize significant hyposalivation. Normal stimulated flow (paraffin chewing or citric acid) is greater than 0.7 mL/min.
🏥Diagnostic Workup for Xerostomia
Fonte: American Dental Association and EULAR criteria
Clinical Evaluation
- 1.Xerostomia questionnaire (Xerostomia Inventory — XI): 11 standardized questions
- 2.Examination of the oral mucosa: dryness, erythema, papillary atrophy, fissured tongue
- 3.Tongue depressor test: adhesion of the depressor to the buccal mucosa indicates dryness
- 4.Evaluation of cervical caries and oral candidiasis
Complementary Tests
- 1.Sialometry: measurement of salivary flow at rest and stimulated
- 2.Sialography: contrast radiography of the salivary ducts (stenosis, sialolithiasis)
- 3.Salivary gland ultrasonography: structure, echogenicity, nodules
- 4.Minor salivary gland biopsy (lip): diagnosis of Sjögren (Chisholm-Mason score)
- 5.Anti-SSA/Ro and anti-SSB/La antibodies: serology for Sjögren syndrome
XEROSTOMIA SEVERITY CLASSIFICATION (RTOG/EORTC SCALE)
| GRADE | SALIVARY FLOW | SYMPTOMS | FUNCTIONAL IMPACT |
|---|---|---|---|
| Grade 1 (Mild) | > 0.2 mL/min | Slightly dry mouth | Minimal — no dietary changes |
| Grade 2 (Moderate) | 0.1–0.2 mL/min | Moderately dry mouth, thick saliva | Need for liquids to swallow dry foods |
| Grade 3 (Severe) | < 0.1 mL/min | Severely dry mouth, no visible saliva | Diet restricted to liquid or soft foods, impaired speech |
Differential Diagnosis
Xerostomia can be a symptom of several systemic conditions. Differential diagnosis is essential to identify treatable causes and conditions that require specific follow-up.
DIAGNÓSTICO DIFERENCIAL
Diagnóstico Diferencial
Drug-Induced Xerostomia
- Temporal relationship with the start or adjustment of a medication
- Improvement with discontinuation or change of the drug
- Polypharmacy as a risk factor
Testes Diagnósticos
- Detailed pharmacologic review
- Supervised discontinuation trial
Sjögren Syndrome
- Xerostomia + xerophthalmia (dry eye)
- Arthralgia or arthritis
- Recurrent parotitis
Testes Diagnósticos
- Anti-SSA/Ro and anti-SSB/La
- Minor salivary gland biopsy
Post-Radiation Xerostomia
- History of head and neck radiation therapy
- Onset during or shortly after treatment
- Frequently irreversible character
Testes Diagnósticos
- Salivary gland scintigraphy
- Stimulated sialometry
Uncontrolled Diabetes Mellitus
- Polyuria and polydipsia
- Associated dehydration
- Autonomic neuropathy
Testes Diagnósticos
- Fasting glucose
- Glycated hemoglobin (HbA1c)
Dehydration
- Reduced skin turgor
- Generalized dry mucous membranes
- Postural hypotension
Testes Diagnósticos
- Serum electrolytes
- Renal function
- Evaluation of fluid intake
Conventional Treatment
Treatment of xerostomia depends on the underlying cause and the degree of impairment of glandular function. The approach involves local palliative measures, sialagogue agents (salivary stimulants), and, when possible, treatment of the underlying cause.
In patients with preserved glandular parenchyma (drug-induced xerostomia, early Sjögren), sialagogues can partially restore salivary flow. In cases with advanced glandular destruction (post-radiation with high doses), treatment is predominantly palliative with salivary substitutes.
CONVENTIONAL TREATMENTS FOR XEROSTOMIA
| TREATMENT | MECHANISM | INDICATION | CONSIDERATIONS |
|---|---|---|---|
| Pilocarpine (Salagen) | M3 muscarinic agonist — stimulates salivary secretion | Sjögren, post-radiation | Sweating, nausea, blurred vision as adverse effects |
| Cevimeline (Evoxac) | M1/M3 muscarinic agonist — more selective | Sjögren with residual function | Fewer adverse effects than pilocarpine |
| Salivary substitutes | Artificial replacement — carboxymethylcellulose, mucin | All causes | Temporary relief, requires frequent reapplication |
| Sugar-free chewing gum | Mechanical stimulation of reflex secretion | Residual glandular function | Simple option, aids remineralization with xylitol |
| Topical fluoride | Protection against caries | Dental prevention | Essential in all patients with hyposalivation |
| Medication adjustment | Removal or substitution of the causative drug | Drug-induced xerostomia | First measure when feasible |
Stepwise Therapeutic Approach
Step 1
ContinuousGeneral Measures and Hygiene
Adequate hydration, rigorous oral hygiene, topical fluoride, avoiding irritants (alcohol, tobacco, excess coffee). Chewing gum with xylitol.
Step 2
As neededSalivary Substitutes
Gels and sprays with carboxymethylcellulose or mucin for coating and lubrication of the oral mucosa.
Step 3
Continuous use with monitoringPharmacologic Sialagogues
Pilocarpine (5-10 mg, 3x/day) or cevimeline (30 mg, 3x/day) when there is residual glandular function.
Step 4
8-12 initial sessionsMedical Acupuncture
Indicated as adjuvant therapy or when sialagogues are poorly tolerated. Strong evidence for post-radiation xerostomia.
Acupuncture as Treatment
Acupuncture has robust scientific evidence for the treatment of xerostomia, particularly in radiation-induced xerostomia. Randomized clinical trials published in JAMA Network Open have demonstrated that acupuncture significantly increases salivary flow and reduces dry mouth symptoms.
The study by Garcia et al. (2019), published in JAMA Network Open, demonstrated that true acupuncture was superior to sham acupuncture in preventing severe xerostomia in patients undergoing radiation therapy for head and neck cancer. The multicenter trial by Cohen et al. (2024), also published in JAMA, confirmed durable benefit of acupuncture for chronic post-radiation xerostomia.
The quality of this evidence is notable: randomized, sham-controlled, multicenter trials with prolonged follow-up — the most rigorous standard possible for evaluating acupuncture interventions.
Neurophysiologic Mechanisms
The most accepted mechanistic hypothesis is that acupuncture stimulates salivary flow through convergent neurologic pathways. Insertion of needles at points on the face and neck would activate afferent fibers of the trigeminal nerve (cranial nerve V) and the facial nerve (cranial nerve VII), which project to the superior salivatory nucleus in the brainstem.
This reflex would theoretically increase parasympathetic discharge via the chorda tympani nerve (branch of cranial nerve VII) and via the glossopharyngeal nerve (cranial nerve IX), stimulating M3 muscarinic receptors on acinar cells and favoring aqueous salivary secretion. This is the proposed pathophysiologic model — still under clinical investigation.
Other suggested mechanisms, still partially characterized, include possible increased local blood flow in the salivary glands, release of vasoactive neuropeptides (CGRP, substance P), and modulation of the neuroendocrine axis. These findings are based on experimental and preclinical studies and require further confirmation in humans.
Treatment Protocol
The typical clinical protocol for xerostomia includes local points in the facial and submandibular region — close to the salivary glands — combined with distal points on the limbs for autonomic modulation and central analgesia.
The recommended initial cycle is 8 to 12 sessions, performed 2 to 3 times per week in the first 4 weeks, with a progressive reduction in frequency. The therapeutic response is evaluated by sialometry before and after treatment, in addition to standardized symptom questionnaires.
Prognosis
The prognosis of xerostomia varies according to etiology. In cases of drug-induced xerostomia, the condition is frequently reversible with adjustment, switch, or discontinuation of the causative drug.
In post-radiation xerostomia, spontaneous recovery is limited and depends on the total dose received by the glands. With doses below 25-30 Gy, partial recovery may occur in 12-18 months. Above 40 Gy, glandular destruction is generally permanent. Acupuncture can significantly improve residual function even in chronic cases.
In Sjögren syndrome, the course is chronic and progressive, requiring multidisciplinary follow-up coordinated by the physician. Acupuncture can be used as continuous supportive therapy, with periodic maintenance sessions to preserve residual salivary function.
PROGNOSIS BY ETIOLOGY
| CAUSE | REVERSIBILITY | RESPONSE TO ACUPUNCTURE | OBSERVATIONS |
|---|---|---|---|
| Drug-induced | High — with pharmacologic adjustment | Good — adjuvant during the transition | Most common cause and most responsive to intervention |
| Post-radiation (< 30 Gy) | Partial (12-18 months) | Very good — strong evidence | Starting acupuncture early improves results |
| Post-radiation (> 40 Gy) | Low — permanent glandular damage | Moderate — symptomatic improvement | Focus on quality of life and prevention of complications |
| Sjögren Syndrome | Low — chronic progressive course | Moderate to good | Continuous supportive treatment recommended |
| Diabetes | High — with glycemic control | Good — synergistic effect | Metabolic control is the priority |
| Dehydration | High — with fluid replacement | Unnecessary as isolated treatment | Correcting the cause resolves the symptom |
Myths and Facts
Myth vs. Fact
Dry mouth is just a minor annoyance.
Chronic xerostomia drastically increases the risk of rampant caries, oral candidiasis, periodontal disease, and nutritional difficulty. It is a medical condition that requires appropriate treatment.
Drinking more water resolves dry mouth.
Adequate hydration is important, but it does not replace saliva. Water does not contain the enzymes, mucins, and immunoglobulins present in natural saliva. Patients with severe hyposalivation need specific treatment.
There is no effective treatment for post-radiation xerostomia.
Randomized clinical trials published in JAMA have demonstrated that acupuncture significantly increases salivary flow and improves quality of life in patients with post-radiation xerostomia, with benefit maintained for months.
Xerostomia is an inevitable consequence of aging.
Although secretory capacity decreases with age, most older adults with xerostomia have treatable causes — primarily medications. Aging alone rarely causes clinically significant dry mouth.
When to Seek Medical Help
Frequently Asked Questions about Xerostomia
Xerostomia is the subjective sensation of dry mouth — it is the complaint the patient reports. Hyposalivation (or salivary gland hypofunction) is the objective and measurable reduction in salivary flow, diagnosed by sialometry. It is possible to have xerostomia without hyposalivation (saliva production is normal, but the patient feels dry mouth) and hyposalivation without xerostomia (production is reduced, but the patient does not perceive it). However, in most cases, the two conditions coexist.
More than 500 medications list xerostomia as an adverse effect. The most frequent are: tricyclic antidepressants (amitriptyline, nortriptyline), selective serotonin reuptake inhibitors (fluoxetine, sertraline), antihistamines (loratadine, diphenhydramine), antihypertensives (diuretics, beta-blockers, ACE inhibitors), anticholinergics (oxybutynin, tolterodine), opioids, and benzodiazepines. The risk increases with polypharmacy — patients taking 4 or more medications have a significantly higher risk.
The most accepted mechanistic model proposes that acupuncture stimulates afferent fibers of the trigeminal (cranial nerve V), facial (cranial nerve VII), and glossopharyngeal (cranial nerve IX) nerves, which project to the superior salivatory nucleus in the brainstem. This would activate a parasympathetic reflex that promotes salivary secretion by acinar cells via M3 muscarinic receptors. Experimental studies also suggest possible increased local blood flow and release of vasoactive neuropeptides (CGRP, substance P). This neurophysiologic hypothesis still requires more confirmation in human studies.
The evidence is robust and of high quality. The Garcia et al. (2019) study, published in JAMA Network Open, demonstrated that true acupuncture was superior to sham acupuncture in preventing severe xerostomia during radiation therapy. The Cohen et al. (2024) trial, published in JAMA Network Open, confirmed durable benefit for chronic post-radiation xerostomia. These are randomized, sham-controlled, multicenter trials — the most rigorous standard for evaluating clinical interventions.
The recommended initial cycle is 8 to 12 sessions, performed 2 to 3 times per week in the first 4 weeks, with progressive reduction in frequency depending on response. Symptom improvement generally begins between the third and fifth sessions. After the initial cycle, biweekly or monthly maintenance sessions may be indicated to sustain the benefit, especially in post-radiation xerostomia and Sjögren syndrome.
Yes. Although the first measure is pharmacologic adjustment (substitution, dose reduction, or discontinuation of the causative medication), acupuncture can be used as adjuvant therapy while the adjustment is performed or when medication change is not feasible. Stimulation of the parasympathetic salivatory reflex by acupuncture can partially compensate for the muscarinic blockade caused by anticholinergic drugs.
It depends on the radiation dose received by the salivary glands. With doses below 25-30 Gy, partial spontaneous recovery may occur in 12-18 months. Above 40 Gy, destruction of the acinar parenchyma is generally irreversible. Randomized clinical trials suggest that acupuncture can help improve residual salivary function and symptoms in some patients, including in chronic cases — although the magnitude of the response varies individually.
The diagnosis starts from the patient's clinical complaint and examination of the oral cavity (dry mucosa, fissured tongue, cervical caries, candidiasis). Sialometry quantifies salivary flow: at rest, the normal is 0.3-0.4 mL/min and values below 0.1 mL/min indicate significant hyposalivation. To investigate causes, anti-SSA/Ro and anti-SSB/La antibodies (Sjögren), salivary gland ultrasonography, fasting glucose, and detailed pharmacologic review may be requested.
Yes, and the evidence suggests that this is the best time to start it. The Garcia et al. (2019) study demonstrated that acupuncture performed concurrently with radiation therapy was effective in preventing severe xerostomia. The rationale is to preserve residual glandular function before destruction by radiation treatment is complete. The acupuncturist physician coordinates with the oncology team to define the ideal session schedule.
Seek medical evaluation if dry mouth persists for more than 2 weeks, if you notice difficulty swallowing or speaking, if you have rapidly progressing caries, if you perceive persistent oral burning, or if dry mouth is accompanied by dry eye and joint pain (may indicate Sjögren syndrome). Patients taking multiple medications and patients undergoing radiation therapy should be evaluated proactively. An acupuncturist physician can evaluate whether acupuncture is indicated as part of the treatment.
Related Reading
Deepen your knowledge with related articles